Komori
Eisai (4523) · InitiativeFirst stated

Termination of the U.S. Aloxi License Agreement

First written in FY2019-Q1. . Latest entry: FY2019-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Termination of the U.S. Aloxi License AgreementA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019-Q1First statedAnnual report

    「2018年6月、当社の連結子会社であるEisai Inc.(米国)は、同月末日をもってHelsinn Healthcare S.A.(スイス)との制吐剤「Aloxi」(一般名：パロノセトロン)の米国におけるライセンス契約を終結しました。」

    Aloxiの米国ライセンス契約をHelsinn Healthcareとの間で終結した。Aloxiの特許訴訟・ジェネリック上市とは別に、契約関係の終了という事業上の変更が記載された。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Eisai yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.